A new video series from ICAP at Columbia University Mailman School of Public Health explores the Power of PrEP (pre-exposure prophylaxis) — the use of medications to prevent the acquisition of human immunodeficiency (HIV).
The videos — produced on location in Democratic Republic of Congo, Kenya, and Nigeria promote the use of PrEP among members of key populations that are at high risk for acquiring HIV. Each video features a member of a group heavily impacted by HIV — a gay man, a male sex worker, and a female sex worker — all of whom take PrEP to remain HIV-negative.
“With PrEP, health care teams finally have something new to offer people as effective prevention against HIV,” said Dr. Julie Franks, senior research associate for ICAP’s Clinical and Training Unit, who conceived the series. “But it can’t work if people don’t take it. Our hope is that by highlighting how people have experienced the benefit of PrEP, our videos will generate interest for PrEP among potential clients, as well as among health care workers who already offer HIV testing and prevention services, to encourage them to offer PrEP where appropriate.”
Research shows that, when taken daily, PrEP reduces the risk of getting HIV from sex by about 99 percent and from injecting drugs by at least 74 percent.
ICAP is working to introduce PrEP to communities affected by the HIV epidemic around the world. To support this work, ICAP has developed a package of tools to help health care professionals provide PrEP in a safe and effective manner. These tools are available free of charge at: icap.columbia.edu/prep
The project was supported by PEPFAR through the CDC under terms of Cooperative Agreement GH000994.
For more information download ICAP’s Factsheet.Tags: Friday Letter Submission, Publish on February 28